| Name | Title | Contact Details |
|---|
Since 1995, Averhealth has partnered with courts and social service programs nationwide, providing best-in-class drug testing services.
Streamline your business finances with our all-in-one platform. Get business loans, manage expenses, issue corporate cards, and more, Sign up for free.
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.
Providing web design and hosting as well as app and software development services, Onsharp is based in Fargo, ND with offices in Minneapolis and Denver.